These guidelines apply only to employers and individuals who come under the regulatory authority of the U.S. Department of Transportation (DOT) and those individuals who conduct urine specimen collections under DOT regulations. The term “employee” is used throughout this document and has the same meaning as “donor” as used on the Federal Drug Testing Custody and Control Form (CCF).
These guidelines are a complete revision of the DOT Urine Specimen Collection Procedures Guidelines, 49 CFR Part 40, for Transportation Workplace Drug Testing Programs. Download Guideline
Note: All items that are bolded, underlined, and italicized in this revision reflect the changes to the collection procedures and requirements from the Interim Final Rule, published on September 27, 2010, effective October 1, 2010.
Recent Posts
- 07 Nov 2022Incorporating ride-sourcing services into paratransit for people with disabilities: Opportunities and barriers
- 07 Nov 2022Paratransit services for people with disabilities in the Seattle region during the COVID-19 pandemic: Lessons for recovery planning
- 07 Nov 2022Barriers and opportunities for paratransit users to adopt on-demand micro transit
- 07 Nov 2022Intelligent Paratransit
- 07 Nov 2022Hybrid scheduling methods for paratransit operations
- 07 Nov 2022On-demand microtransit and paratransit service using autonomous vehicles: Gaps and opportunities in accessibility policy
- 31 Oct 2022Transit Workforce Shortage
- 25 Oct 2022Serving People with Autism on Transportation
- 12 Oct 2022Microtransit Definitions, Trends, and Applications
- 12 Oct 2022Microtransit: On-Demand and Open to All